This Appropriate Care Guide (ACG) highlights the importance of appropriate anticoagulation and provides clinicians with recommendations on when to initiate anticoagulation, how to select between warfarin and non-vitamin K antagonists, and appropriate follow-up and monitoring of patients.
A supplementary guide on how to switch between agents has also been provided.
Download the PDF below to access the full ACG.
|1.||Offer anticoagulation to patients with atrial fibrillation (AF) and a modified CHA2DS2VASc score of 2 or more.|
|2.||Choose warfarin or a non-vitamin K antagonist oral anticoagulant (NOAC), based on patient, drug and disease factors.
|3.||Review oral anticoagulation at least annually and when patients' clinical circumstances change.|
|4.||Use antiplatelet agents selectively based on risk stratification when anticoagulation is contraindicated. Antiplatelet agents are inferior to anticoagulants for preventing AF-related strokes.|